Frank Xiaoqing Liu - Concepedia

Author

Frank Xiaoqing Liu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Frank Xiaoqing Liu

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)Baxter (United States)Mayo Clinic in Florida Hospital Fernandes Távora Jefferson Hospital

About

Frank Xiaoqing Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, health economics, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	305
2	Public Health	3	3	139
3	Health Sciences	2	2	96
4	Emergency Medicine	2	2	86
5	Clinical Nutrition	1	1	58

Frank Xiaoqing Liu

Publications

Citations

H-Index

Page 1

	Year	Citations
Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States Min Huang, Yanyan Lou, James M. Pellissier, PharmacoEconomics MedicinePharmacologyMetastatic NsclcImmune Checkpoint InhibitorPharmacotherapy	2017	148
Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States Vamsidhar Velcheti, Pallavi Patwardhan, Frank Xiaoqing Liu, PLoS ONE	2018	69
Bloodstream Infections Associated With Parenteral Nutrition Preparation Methods in the United States Robin S. Turpin, Todd W. Canada, Víctor Rosenthal, Journal of Parenteral and Enteral Nutrition	2011	66
Economic Evaluation of Urgent-Start Peritoneal Dialysis Versus Urgent-Start Hemodialysis in the United States Frank Xiaoqing Liu, Arshia Ghaffari, Harman Dhatt, Medicine Dialysis TherapyCost ModelUnited StatesPrimary CarePublic Health	2014	65
Peritoneal Dialysis and In-Centre Haemodialysis: A Cost-Utility Analysis from a UK Payer Perspective Catrin Treharne, Frank Xiaoqing Liu, Lydia Crowe, Applied Health Economics and Health Policy	2014	63
Cost-Effectiveness of Pembrolizumab Versus Ipilimumab in Ipilimumab-Naïve Patients with Advanced Melanoma in the United States Jingshu Wang, Bartosz Chmielowski, James M. Pellissier, Journal of Managed Care & Specialty Pharmacy	2017	61
Nutrition Therapy Cost Analysis in the US Robin S. Turpin, Todd W. Canada, Frank Xiaoqing Liu, Applied Health Economics and Health Policy NutritionHealth EconomicsClinical NutritionCost EffectivenessPublic Health	2011	58
Cost-effectiveness of pembrolizumab versus docetaxel for the treatment of previously treated PD-L1 positive advanced NSCLC patients in the United States Min Huang, Yanyan Lou, James M. Pellissier, Journal of Medical Economics	2016	56
The Impact of Medicare Part D on Out-of-Pocket Costs for Prescription Drugs, Medication Utilization, Health Resource Utilization, and Preference-Based Health Utility Frank Xiaoqing Liu, G. Caleb Alexander, Stephanie Y. Crawford, Health Services Research	2011	54
Real-world experience with pembrolizumab in patients with advanced melanoma Frank Xiaoqing Liu, Wanmei Ou, Scott J. Diede, Medicine Neuro-oncologySkin CancerMedicineLactate DehydrogenaseMelanoma	2019	38

Page 1